Peter Chedraui

Position Statement, 090-092 | DOI: 10.53260/grem.245025

Position statement of the Latin American Federation of Climacteric and Menopause Societies (FLASCYM) regarding the use of Bioidentical Hormonal Compounds during female mid-life

Cuauhtémoc Celis-Gonzales, María S. Vallejo-Maldonado, Juan E. Blumel, Luis Hernández-Guzmán, Alejandro Paradas-Caba, Nestor Siseles, Zully Benítez-Roa, Hoover Canaval-Erazo, Nilson Roberto De Melo, Peter Chedraui

Position paper, 070-073 | DOI: 10.53260/grem.22302031

ISGE Statement on Purified and Specific Cytoplasmic Pollen Extract, PureCyTonin® as a non-hormonal alternative for the treatment of menopausal symptoms

Andrea Riccardo Genazzani, Leila Adamyan, Sarah Berga, Martin Birkhaeuser, Mark Brincat, Antonio Cano, Cuauhtemoc Celis, Peter Chedraui, Nilson Roberto De Melo, Blazej Meczekalski, Alfred O. Mueck, Frederick Naftolin, Rossella E. Nappi, Nicola Pluchino, Xiangyan Ruan, Tommaso Simoncini, Nestor Siseles, John C. Stevenson, Charles Sultan, Basil C. Tarlatzis, Svetlana Vujović, Andrzej Milewicz

Review, 070-075 | DOI: 10.53260/grem.201021

The coronavirus disease (COVID) 2019 and human pregnancy: A scoping review

Ricardo Savirón-Cornudella, Iván E. Altamirano-Barcia, Peter Chedraui, Mercedes Andeyro-García, Mauricio Tajada, Faustino R. Pérez-López

GREM - Gynecological and Reproductive Endocrinology & Metabolism

Peter Chedraui

Peter Chedraui appears in:

Position statement of the Latin American Federation of Climacteric and Menopause Societies (FLASCYM) regarding the use of Bioidentical Hormonal Compounds during female mid-life

ISGE Statement on Purified and Specific Cytoplasmic Pollen Extract, PureCyTonin® as a non-hormonal alternative for the treatment of menopausal symptoms

The coronavirus disease (COVID) 2019 and human pregnancy: A scoping review